Imaging 26S proteasome activity and inhibition in living mice (original) (raw)

• Sakamoto, K. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Mol. Genet. Metab. 77, 44–56 (2002).
  Article CAS PubMed Google Scholar
• Glickman, M. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373–428 (2002).
  Article CAS PubMed Google Scholar
• Pye, J. et al. Proteasome inhibition ablates activation of NF-κB induced during myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 284, H919–H926 (2002).
  Article PubMed Google Scholar
• Zhang, L. et al. Postischemic (6-hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia. Stroke 32, 2926–2931 (2001).
  Article CAS PubMed Google Scholar
• Adams, J. Proteasome inhibitors as new anticancer drugs. Curr. Opin. Oncol. 14, 628–634 (2002).
  Article CAS PubMed Google Scholar
• Hideshima, T. & Anderson, K. Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat. Rev. Cancer 2, 927–937 (2002).
  Article CAS PubMed Google Scholar
• Voges, D., Zwickl, P. & Baumeister, W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68, 1015–1068 (1999).
  Article CAS PubMed Google Scholar
• Navon, A. & Goldberg, A. Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol. Cell 8, 1339–1349 (2001).
  Article CAS PubMed Google Scholar
• Leggett, D. et al. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 10, 495–507 (2002).
  Article CAS PubMed Google Scholar
• Lightcap, E. et al. Proteasome inhibition measurements: clinical application. Clin. Chem. 46, 673–683 (2000).
  CAS PubMed Google Scholar
• Stack, J., Whitney, M., Rodems, S. & Pollok, B. A ubiquitin-based tagging system for controlled modulation of protein stability. Nat. Biotechnol. 18, 1298–1302 (2000).
  Article CAS PubMed Google Scholar
• Kang, Z., Pirskanen, A., Janne, O. & Palvimo, J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277, 48366–48371 (2002).
  Article CAS PubMed Google Scholar
• Deroo, B. & Archer, T. Proteasome inhibitors reduce luciferase and beta-galactosidase activity in tissue culture cells. J. Biol. Chem. 277, 20120–20123 (2002).
  Article CAS PubMed Google Scholar
• Kisselev, A. & Goldberg, A. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8, 739–758 (2001).
  Article CAS PubMed Google Scholar
• Lin, G. et al. Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding. Nat. Struct. Biol. 4, 539–547 (1997).
  Article CAS PubMed Google Scholar
• Welsh, S. & Kay, S. Reporter gene expression for monitoring gene transfer. Curr. Opin. Biotechnol. 8, 617–622 (1997).
  Article CAS PubMed Google Scholar
• Dantuma, N., Lindsten, K., Glas, R., Jeline, M. & Masucci, M. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538–543 (2000).
  Article CAS PubMed Google Scholar
• LeBlanc, R. et al. Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. Cancer Res. 62, 4996–5000 (2002).
  CAS PubMed Google Scholar
• Adams, J. Proteasome inhibition: a novel approach to cancer therapy. Trends Mol. Med. 8, S49–S54 (2002).
  Article CAS PubMed Google Scholar
• Orlowski, R. et al. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J. Clin. Oncol. 20, 4420–4427 (2002).
  Article CAS PubMed Google Scholar
• Johnson, E., Bartel, B., Seufert, W. & Varshavsky, A. Ubiquitin as a degradation signal. EMBO J. 11, 497–505 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Bence, N., Sampat, R. & Kopito, R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552–1555 (2001).
  Article CAS PubMed Google Scholar